Evidence map›Paper›PMID 21870852›Full record

ReviewChemical research in toxicology2011

Critical insights into cardiovascular disease from basic research on the oxidation of phospholipids: the γ-hydroxyalkenal phospholipid hypothesis.

Robert G Salomon, Xiaodong Gu

Abstract readReview
In one paragraph

Review in Chemical research in toxicology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Robert G SalomonDepartment of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106-7078, USA. rgs@case.edu
Xiaodong Gu

Funding

Preprostaglandin Endoperoxides (supplement)R01GM021249 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI SALOMON, ROBERT GERD · 1985 to 2014
$5.2M
REACTIVE INTERMEDIATES OF OXIDATIVE LIPID FRAGMENTATIONR01EY016813 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI SALOMON, ROBERT GERD · 2006 to 2018
$3.9M
MOLECULAR BASIS OF OXIDATIVE MODIFICATION OF LDLR01HL053315 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI SALOMON, ROBERT GERD · 1996 to 2010
$3.4M
NEI NIH HHS EY016813NEI NIH HHS R01 EY016813NHLBI NIH HHS HL53315NHLBI NIH HHS R01 HL053315NIGMS NIH HHS GM021249NIGMS NIH HHS R01 GM021249
6 · The paper itself

Abstract

Basic research, exploring the hypothesis that γ-hydroxyalkenal phospholipids are generated in vivo through oxidative cleavage of polyunsaturated phospholipids, is delivering a bonanza of molecular mechanistic insights into cardiovascular disease. Rather than targeting a specific pathology, these studies were predicated on the presumption that a fundamental understanding of lipid oxidation is likely to provide critical insights into disease processes. This investigational approach, from the chemistry of biomolecules to disease phenotype, that complements the more common opposite paradigm, is proving remarkably productive.

Indexed as

Lipid MetabolismOxidation-ReductionProtein Processing, Post-TranslationalAldehydesAnimalsBiological TransportCardiovascular DiseasesCD36 AntigensCoronary VesselsFree RadicalsHeartHepatocytesHumansLipoproteins, LDLLysophosphatidylcholinesMice4-hydroxy-2-nonenalAldehydesCD36 AntigensFree RadicalsLipoproteins, LDLLysophosphatidylcholinesSCARB1 protein, humanScavenger Receptors, Class BTLR2 protein, humanToll-Like Receptor 2

Identifiers

PMID21870852
PMCPMC3221896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.